ErbB-4: A receptor tyrosine kinase

Inflammation Research

Volumn 51, Issue 2, 2002, Pages 91-101

  Zhou, W ^a   Carpenter, Graham ^a  

^a VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

ErB 4; Growth factor; Heregulin; Receptor; Tyrosine kinase

Indexed keywords

CELL PROTEIN; EPIDERMAL GROWTH FACTOR RECEPTOR 4; GROWTH FACTOR; LIGAND; PROTEIN TYROSINE KINASE; UNCLASSIFIED DRUG;

AUTOPHOSPHORYLATION; CARCINOGENESIS; CELL DIFFERENTIATION; CELL PROLIFERATION; EMBRYO DEVELOPMENT; ENDOCYTOSIS; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME STRUCTURE; HUMAN; INTRACELLULAR TRANSPORT; NONHUMAN; PROTEIN DEGRADATION; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; PROTEIN TARGETING; PROTEIN TRANSPORT; RECEPTOR DOWN REGULATION; REVIEW; SIGNAL TRANSDUCTION;

AMINO ACID SEQUENCE; ANIMALS; BINDING SITES; ENDOPEPTIDASES; ENZYME ACTIVATION; GENE EXPRESSION; GROWTH SUBSTANCES; HUMANS; MOLECULAR SEQUENCE DATA; RECEPTOR, EPIDERMAL GROWTH FACTOR; SIGNAL TRANSDUCTION;

EID: 0036185876     PISSN: 10233830     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF02684009     Document Type: Review

References (168)

1. The ErbB signaling network in embryogenesis and oncogenesis: Signal diversification through combinatorial ligand-receptor interactions
2. Specificity within the EGF family/ErbB receptor family signaling network
3. Take your partners, please - Signal diversification by the erbB family of receptor tyrosine kinases
4. Activation of HER4 by heparin-binding EGF-like growth factor stimulates chemotaxis but not proliferation
5. Activation of ErbB4 by the bifunctional epidermal growth factor family hormone epiregulin is regulated by ErbB2
6. Epiregulin binds to epidermal growth factor receptor and ErbB-4 and induces tyrosine phosphorylation of epidermal growth factor receptor, ErbB-2, ErbB-3 and ErbB-4
7. Glial growth factors are alternatively spliced erbB2 ligands expressed in the nervous system
8. ARIA, a protein that stimulates acetylcholine receptor synthesis, is a member of the Neu ligand family
9. Neu differentiation factor: A Transmembrane glycoprotein containing an EGF domain and an immunoglobulin homology unit
10. erbB2
11. Ligands for ErbB-family receptors encoded by a neuregulin-like gene
12. Neuregulin-2, a new ligand of ErbB3/ErbB4-receptor tyrosine kinases
13. Neuregulin-3 (NRG3): A novel neural tissue-enriched protein that binds and activates ErbB4
14. Neuregulin-4: A novel growth factor that acts through the ErbB-4 receptor tyrosine kinase
15. Bivalence of EGF-like ligands drives the ErbB signaling network
16. Controlled dimerization of ErbB receptors provides evidence of differential signaling by homo- and heterodimers
17. Extracellular domains drive homo- but not hetero-dimerization of erbB receptors
18. Epidermal Growth Factor
19. The role of individual SH2 domains in mediating association of phospholipase C-γ1 with the activated EGF receptor
20. Endocytosis and intracellular sorting of receptor tyrosine kinases
21. The EGF receptor: A nexus for trafficking and signaling
22. All ErbB receptors other than the epidermal growth factor receptor are endocytosis impaired
23. (1995) Requirement for neuregulin receptor erbB2 in neural and cardiac development
24. Aberrant neural and cardiac development in mice lacking the ErbB4 neuregulin receptor
25. Targeted disruption of mouse EGF receptor: Effect of genetic background on mutant phenotype
26. Epithelial immaturity and multiorgan failure in mice lacking epidermal growth factor receptor
27. Severe neuropathies in mice with targeted mutations in the ErbB3 receptor
28. ErbB3 is required for normal cerebellar and cardiac development: A comparison with ErbB2- and heregulin-deficient mice
29. Type 1 receptor tyrosine kinases are differentially phosphorylated in mammary carcinoma and differentially associated with steroid receptors
30. The type 1 growth factor receptor family: New ligands and receptors and their role in breast cancer
31. Frequent expression of a mutant epidermal growth factor receptor in multiple human tumors
32. The enhanced tumorigenic activity of a mutant epidermal growth factor receptor common in human cancers is mediated by threshold levels of constitutive tyrosine phosphorylation and unattenuated signaling
33. 1 cell-cycle arrest pathways to induce glioma-like lesions in mice
34. Localization of the human HER4/erbB-4 gene to chromosome 2
35. Chromosomal localisation of the human homologues to the oncogenes erbA and B
36. Tyrosine kinase receptor with extensive homology to EGF receptor shares chromosomal location with neu oncogene
37. Localization of the human erbB-2 gene on normal and rearranged chromosomes 17 to bands q12-21.32
38. Isolation and characterization of ERBB3, a third member of the ERBB/epidermal growth factor receptor family: Evidence for overexpression in a subset of human mammary tumors
39. erbB4, a fourth member of the epidermal growth factor receptor family
40. Neuregulin signaling in the heart. Dynamic targeting of erbB4 to caveolar microdomains in cardiac myocytes
41. HER4-mediated biological and biochemical properties in NIH 3T3 cells. Evidence for HER1-HER4 heterodimers
42. Analysis of Grb7 recruitment by heregulin-activated erbB receptors reveals a novel target selectivity for erbB3
43. ErbB4 signaling in the mammary gland is required for lobuloalveolar development and Stat5 activation during lactation
44. Characterization of a naturally occurring ErbB4 isoform that does not bind or activate phosphatidyl inositol 3-kinase
45. The neuregulin receptor ErbB-4 interacts with PDZ-containing proteins at neuronal synapses
46. A novel juxtamembrane domain isoform of HER4/ErbB4. Isoform-specific tissue distribution and differential processing in response to phorbol ester
47. Two erbB-4 transcripts are expressed in normal breast and in most breast cancers
48. Synapse-associated expression of an acetylcholine receptor-inducing protein, ARIA/heregulin, and its putative receptors, ErbB2 and ErbB3, in developing mammalian muscle
49. erbB genes in the mouse uterus: Cell-specific signaling by epidermal growth factor (EGF) family of growth factors during implantation
50. Distribution of neuregulin-1 (nrg1) and erbB4 transcripts in embryonic chick hindbrain
51. A natural erbB4 isoform that does not activate phosphoinositide 3-kinase mediates proliferation but not survival or chemotaxis
52. Expression of the c-erbB-4/HER4 protein and mRNA in normal human fetal and adult tissues and in a survey of nine solid tumour types
53. Differential expression of ErbB3 and ErbB4 neuregulin receptors in dopamine neurons and forebrain areas of the adult rat
54. Expression of receptors for neuregulins, ErbB2, ErbB3, and ErbB4, in developing mouse cerebellum
55. Neuregulin and erbB receptor expression in normal and diseased human white matter
56. ErbB-3 and ErbB-4 expression in the mouse olfactory system
57. Effects of GGF/neuregulins on neuronal survival and neurite outgrowth correlate with erbB2/neu expression in developing rat retina
58. Expression of the EGF receptor family members ErbB2, ErbB3, and ErbB4 in germinal zones of the developing brain and in neurosphere cultures containing CNS stem cells
59. Expression of the ErbB-neuregulin signaling network during human cerebellar development: Implications for the biology of medulloblastoma
60. Neuregulin receptors, erbB3 and erbB4, are localized at neuromuscular synapses
61. Changes in ErbB2 (her-2/neu), ErbB3, and ErbB4 during growth, differentiation, and apoptosis of normal rat mammary epithelial cells
62. Neuregulin activation of ErbB receptors in vascular endothelium leads to angiogenesis
63. GGF/neuregulin is a neuronal signal that promotes the proliferation and survival and inhibits the differentiation of oligodendrocyte progenitors
64. Neuregulins and ErbB receptors in cultured neonatal astrocytes
65. Constitutive proteolysis of the erbB-4 receptor tyrosine kinase by a unique, sequential mechanism
66. Neuregulin and erbB receptors play a critical role in neuronal migration
67. Differential expression of NDF/neuregulin receptors ErbB-3 and ErbB-4 and involvement in inhibition of neuronal differentiation
68. Neuregulins promote survival and growth of cardiac myocytes. Persistence of ErbB2 and ErbB4 expression in neonatal and adult ventricular myocytes
69. Characteristics of EGFR family-mediated HRG signals in human ovarian cancer
70. ErbB receptor expression and growth response to heregulin β1 in five ovarian carcinoma lines
71. Tyrosine phosphorylation of ErbB4 is stimulated by aurintricarboxylic acid in human neuroblastoma HS-SY5Y cells
72. Expression of mRNA for heregulin and its receptor, erbB3 and erbB4, in human upper gastrointestinal mucosa
73. Expression of p185erbB-2, p160erbB-3, p180erbB-4, and heregulin α in human normal bronchial epithelial and lung cancer cell lines
74. 3
75. Neu differentiation factors: A family of alternatively spliced neuronal and mesenchymal factors
76. Neuregulins and their receptors: A versatile signaling module in organogenesis and oncogenesis
77. Structural and functional aspects of the multiplicity of neu differentiation factors
78. Binding specificities and affinities of egf domains for ErbB receptors
79. Structure-function and biological role of betacellulin
80. Epidermal growth factor-related peptides activate distinct subsets of ErbB receptors and differ in their biological activities
81. Heparin-binding EGF-like growth factor
82. Heparin-binding EGF-like growth factor interacts with mouse blastocysts independently of ErbB1: A possible role for heparan sulfate proteoglycans and ErbB4 in blastocyst implantation
83. The epidermal growth factor receptor couples transforming growth factor-α, heparin-binding epidermal growth factor-like factor, and amphiregulin to Neu, ErbB-3, and ErbB-4
84. Epiregulin is a potent pan-erbB ligand that preferentially activates heterodimeric receptor complexes
85. Binding interaction of the heregulinβ egf domain with erbB3 and erbB4 receptors assessed by alanine scanning mutagenesis
86. erbB4
87. Sensory and motor neuron-derived factor. A novel heregulin variant highly expressed in sensory and motor neurons
88. Sensory and motor neuron-derived factor is a transmembrane heregulin that is expressed on the plasma membrane with the active domain exposed to the extracellular environment
89. ErbB tyrosine kinases and the two neuregulin families constitute a ligand-receptor network
90. NRG-3 in human breast cancer: Activation of multiple erbB family proteins
91. γ-Heregulin: A novel heregulin isoform that is an autocrine growth factor for the human breast cancer cell line, MDA-MB-175
92. γ-heregulin is the product of a chromosomal translocation fusing the DOC4 and HGL/NRG1 genes in the MDA-MB-175 breast cancer cell line
93. A novel brain-derived member of the epidermal growth factor family that interacts with erbB3 and erbB4
94. NTAKα and β isoforms stimulate breast tumor cell growth by means of different receptor combinations
95. Characterization of a neuregulin-related gene, Don-1, that is highly expressed in restricted regions of the cerebellum and hippocampus
96. ErbB-3 and erbB-4 function as the respective low and high affinity receptors of all neu differentiation factor/heregulin isoforms
97. A novel epidermal growth factor-like molecule containing two follistatin modules stimulates tyrosine phosphorylation of erbB-4 in MKN28 gastric cancer cells
98. Human betacellulin, a member of the EGF family dominantly expressed in pancreas and small intestine, is fully active in a monomeric form
99. Ligand discrimination in signaling through an erbB4 receptor homodimer
100. Heregulin-dependent trafficking and cleavage of erbB-4
101. ErbB-4 activation promotes neurite outgrowth in PC12 cells
102. ErbB2 expression increases the spectrum and potency of ligand-mediated signal transduction through erbB4
103. Formation of a high affinity heregulin binding site using the soluble extracellular domains of erbB2 with erbB3 or erbB4
104. A hierarchical network of interreceptor interactions determines signal transduction by neu differentiation factor/neuregulin and epidermal growth factor
105. Molecular characterization of a gene of the "EGF family" expressed in undifferentiated human NTERA2 teratocarcinoma cells
106. Cripto enhances the tyrosine phosphorylation of Shc and activates mitogen-activated protein kinase (MAPK) in mammary epithelial cells
107. Cripto-1 indirectly stimulates the tyrosine phosphorylation of erbB-4 through a novel receptor
108. A common requirement for the catalytic activity and both SH2 domains of SHP-2 in mitogen-activated protein (MAP) kinase activation by the ErbB family of receptors. A specific role for SHP-2 in MAP, but not c-June amino-terminal kinase activation
109. HER4 Receptor activation and phosphorylation of Shc proteins by recombinant heregulin-Fc fusion proteins
110. Signal transduction pathways induced by heregulin in MDA-MB-453 breast cancer cells
111. Heregulin (HRG)-induced mitogenic signaling and cytotoxic activity of a HRG/PE40 ligand toxin in human breast cancer cells
112. Integrin-linked kinase regulates phosphorylation of serine 473 of protein kinase B by an indirect mechanism
113. ErbB receptor-induced activation of Stat transcription factors is mediated by Src tyrosine kinase
114. Association of STATs with relatives and friends
115. Multiple positive and negative regulators of signaling by the EGF-receptors
116. ErbB-1 and ErbB-2 acquire distinct signaling properties dependent upon their dimerization partner
117. The ins and outs of caveolar signaling m2 muscarinic cholinergic receptors and eNOS activation versus neuregulin and ErbB4 signaling in cardiac myocytes
118. Regulated migration of epidermal growth factor receptor from caveolae
119. Epidermal growth factor receptor activation is localized within low-buoyant density, noncaveolar membrane domains
120. Localization of epidermal growth factor-stimulated Ras/Raf-1 interaction to caveolae membrane
121. Platelet-derived growth factor activates mitogen-activated protein kinase in isolated caveolae
122. Localization of platelet-derived growth factor-stimulated phosphorylation cascade to caveolae
123. Engagement of T cell receptor triggers its recruitment to low-density detergent-insoluble membrane domains
124. Regulation of neuregulin signaling by PSD-95 interacting with ErbB4 at CNS synapses
125. Human postsynaptic density-95 (PSD95): Location of the gene (DLG4) and possible function in nonneural as well as in neural tissues
126. PDZ domains in synapse assembly and signalling
127. ERBIN: A basolateral PDZ protein that interacts with the mammalian ERBB2/HER2 receptor
128. Unique carboxylterminal sequences of wild type and alternatively spliced variant forms of transforming growth factor-α precursors mediate specific interactions with ErbB4 and ErbB2
129. Selective cleavage of the heregulin receptor ErbB-4 by protein kinase C activation
130. Tyrosine phosphorylation and proteolysis. Pervanadate-induced metalloprotease-dependent cleavage of the ErbB-4 receptor and amphiregulin
131. Tumor necrosis factor-α-converting enzyme is required for cleavage of erbB4/HER4
132. Cloning of a disintegrin metalloproteinase that processes precursor tumour-necrosis factor-α
133. A metalloproteinase disintegrin that releases tumour-necrosis factor-α from cells
134. The ADAM gene family. Surface proteins with adhesion and protease activity
135. Metalloprotease-disintegrins: Modular proteins capable of promoting cell-cell interactions and triggering signals by protein-ectodomain shedding
136. An essential role for ectodomain shedding in mammalian development
137. Evidence that tumor necrosis factor a converting enzyme is involved in regulated α-secretase cleavage of the Alzheimer amyloid protein precursor
138. In vitro and in vivo release of soluble erbB-2 protein from human carcinoma cells
139. Elevated soluble c-erbB-2 antigen levels in the serum and effusions of a proportion of breast cancer patients
140. The extracellular domain of the c-erbB-2 oncoprotein is released from tumor cells by proteolytic cleavage
141. 2-terminally truncated HER-2/neu protein: Relationship with shedding of the extracellular domain and with prognostic factors in breast cancer
142. Multiple essential functions of neuregulin in development
143. Chondroitin sulphate-binding molecules may patter central projections of sensory axons within the cranial mesenchyme of the developing mouse
144. Defects in pathfinding by cranial neural crest cells in mice lacking the neuregulin receptor ErbB4
145. Temporal and spatial expression of erbB4 in ectodermal and mesenchymal cells during primary palatogenesis in noncleft and cleft strains of mice
146. Neuregulins signaling via a glial erbB-2-erbB-4 receptor complex contribute to the neuroendocrine control of mammalian sexual development
147. Distinct characteristics of heregulin signals mediated by HER3 or HER4
148. Transformation of NIH 3T3 cells by HER3 or HER4 receptors requires the presence of HER1 or HER2
149. Neuregulin is a mitogen and survival factor for olfactory bulb ensheathing cells and an isoform is produced by astrocytes
150. Neuregulin-β induces expression of an NMDA-receptor subunit
151. Neuregulin in cardiac hypertrophy in rats with aortic stenosis. Differentiation expression of erbB2 and erbB4 receptors
152. ErbB-4 ribozymes abolish neuregulin-induced mitogenesis
153. Ribozyme-mediated down-regulation of erbB-4 in estrogen receptor-positive breast cancer cells inhibits proliferation both in vitro and in vivo
154. Neu differentiation factor activation of erbB-3 and erbB-4 is cell specific and displays a differential requirement for erbB-2
155. Amplification of erbB-4 oncogene occurs less frequently than that of erbB-2 in primary human breast cancer
156. c-erbB3 and c-erbB4 expression is a feature of the endocrine responsive phenotype in clinical breast cancer
157. c-erbB-4 protein expression in human breast cancer
158. Nuclear expression of the c-erbB-4/HER-4 growth factor receptor in invasive breast cancers
159. ErbB-4 mRNA expression is decreased in nonmetastatic pancreatic cancer
160. Tissue expression of neu differentiation factor/heregulin and its receptor complex in prostate cancer and its biologic effects on prostate cancer cells in vitro
161. Expression of c-erbB-3 and c-erbB-4 proteins in papillary thyroid carcinomas
162. Expression of the c-erbB-3/HER-3 and c-erbB-4/HER-4 growth factor receptors and their ligands, neuregulin-1 α, neuregulin-1 β, and betacellulin, in normal endometrium and endometrial cancer
163. Granulosa cell tumors express erbB4 and are sensitive to the cytotoxic action of heregulin-beta2/PE40
164. Prognostic significance of HER2 and HER4 coexpression in childhood medulloblastoma
165. Expression of c-erbB proto-oncogene family members in squamous cell carcinoma of the head and neck
166. The expression of type I growth factor receptors in the squamous neoplastic changes of uterine cervix